Pregabalin 225mg Capsules

Manufacturer GREENSTONE Active Ingredient Pregabalin Capsules(pre GAB a lin) Pronunciation pre GAB a lin
It is used to help control certain kinds of seizures.It is used to treat painful nerve diseases.It is used to treat fibromyalgia.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Anticonvulsant, Neuropathic Pain Agent
🧬
Pharmacologic Class
Gamma-aminobutyric acid (GABA) analogue
🀰
Pregnancy Category
C
βœ…
FDA Approved
Dec 2004
βš–οΈ
DEA Schedule
Schedule V

Overview

ℹ️

What is this medicine?

Pregabalin is a medication used to treat certain types of nerve pain (like from diabetes, shingles, or spinal cord injury), fibromyalgia (a condition causing widespread body pain), and certain types of seizures. It works by calming overactive nerve signals in the brain and body.
πŸ“‹

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication as directed, with or without food. Continue taking it even if you feel well, unless your doctor or healthcare provider advises you to stop.

Storing and Disposing of Your Medication

Store your medication in its original container at room temperature in a dry place, away from the bathroom. Keep it out of reach of children and pets, and store it in a secure location where others cannot access it, such as a locked box or area.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
πŸ’‘

Lifestyle & Tips

  • Do not stop taking Pregabalin suddenly without consulting your doctor, as this can lead to withdrawal symptoms (e.g., insomnia, nausea, headache, anxiety, diarrhea, flu-like symptoms, nervousness, depression, pain, convulsions).
  • Avoid alcohol and other CNS depressants (e.g., opioids, benzodiazepines) while taking Pregabalin, as this can increase dizziness, drowsiness, and risk of respiratory depression.
  • Be cautious when driving or operating machinery until you know how Pregabalin affects you, as it can cause dizziness and drowsiness.
  • Report any new or worsening mood changes, depression, or suicidal thoughts to your doctor immediately.
  • Report any unexplained muscle pain, tenderness, or weakness, especially if accompanied by fever or malaise.
  • Report any swelling of the face, lips, tongue, or throat, or difficulty breathing, as these could be signs of a serious allergic reaction (angioedema).

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Varies by indication. For neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia): Initial 50 mg three times daily (TID) or 75 mg twice daily (BID), titrated up to 100 mg TID or 150 mg BID (300 mg/day) within 1 week. Max 300 mg TID (600 mg/day). For fibromyalgia: Initial 75 mg BID, titrated to 150 mg BID (300 mg/day) within 1 week. Max 225 mg BID (450 mg/day). For partial onset seizures (adjunctive): Initial 75 mg BID or 50 mg TID, titrated to 150-300 mg BID or 100-200 mg TID (300-600 mg/day). Max 600 mg/day.
Dose Range: 150 - 600 mg

Condition-Specific Dosing:

Diabetic Peripheral Neuropathy: Initial 50 mg TID or 75 mg BID; maintenance 100 mg TID or 150 mg BID (300 mg/day); max 600 mg/day.
Postherpetic Neuralgia: Initial 75 mg BID; maintenance 150 mg BID (300 mg/day); max 600 mg/day.
Fibromyalgia: Initial 75 mg BID; maintenance 150 mg BID (300 mg/day); max 450 mg/day.
Adjunctive Therapy for Partial Onset Seizures: Initial 75 mg BID or 50 mg TID; maintenance 150-300 mg BID or 100-200 mg TID (300-600 mg/day); max 600 mg/day.
Neuropathic Pain associated with Spinal Cord Injury: Initial 75 mg BID; maintenance 150-300 mg BID (300-600 mg/day); max 600 mg/day.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for most indications; limited data for adjunctive therapy of partial onset seizures in children 4 years and older (dosing based on weight, typically 3.5-10 mg/kg/day in 2-3 divided doses, max 600 mg/day).
Adolescent: Similar to adult dosing for adjunctive therapy of partial onset seizures (typically 300-600 mg/day in 2-3 divided doses).
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: CrCl >60 mL/min: No adjustment needed.
Moderate: CrCl 30-60 mL/min: Reduce total daily dose by 50% (e.g., 75-300 mg/day in 2-3 divided doses).
Severe: CrCl 15-30 mL/min: Reduce total daily dose by 75% (e.g., 25-150 mg/day in 1-2 divided doses).
Dialysis: CrCl <15 mL/min: Reduce total daily dose by 80-90% (e.g., 25-75 mg/day in 1 divided dose). A supplemental dose (e.g., 25-100 mg) should be given immediately following a 4-hour hemodialysis session.

Hepatic Impairment:

Mild: No adjustment
Moderate: No adjustment
Severe: No adjustment (Pregabalin is minimally metabolized by the liver)

Pharmacology

πŸ”¬

Mechanism of Action

Pregabalin binds with high affinity to the alpha2-delta (Ξ±2-Ξ΄) subunit of voltage-gated calcium channels in the central nervous system. While the precise mechanism of action is unknown, binding to the Ξ±2-Ξ΄ subunit is thought to modulate the release of several excitatory neurotransmitters, including glutamate, norepinephrine, and substance P, which may contribute to its analgesic, anxiolytic, and anticonvulsant effects.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: >=90%
Tmax: 1.5 hours (fasted state)
FoodEffect: Food decreases Cmax by 25-30% and prolongs Tmax to approximately 3 hours, but does not significantly affect the extent of absorption (AUC).

Distribution:

Vd: Approximately 0.56 L/kg
ProteinBinding: <1%
CnssPenetration: Yes

Elimination:

HalfLife: 6.3 hours
Clearance: Approximately 67 mL/min (renal clearance)
ExcretionRoute: Renal (primarily as unchanged drug)
Unchanged: >90%
⏱️

Pharmacodynamics

OnsetOfAction: Within 1 week for pain relief; within days for anxiolytic effects; variable for seizure control.
PeakEffect: Typically within 1-2 weeks of reaching stable dose for chronic conditions.
DurationOfAction: Approximately 8-12 hours (consistent with BID/TID dosing).

Safety & Warnings

⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you or your caregiver notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Changes in eyesight
Muscle pain or weakness
Changes in balance
Feeling confused
Shakiness
Trouble breathing, slow breathing, or shallow breathing
Blue or gray color of the skin, lips, nail beds, fingers, or toes
Memory problems or loss
Shortness of breath, significant weight gain, or swelling in the arms or legs
Fast or abnormal heartbeat
Fever, chills, or sore throat
Skin sores or any skin changes
Trouble speaking
Trouble sleeping
Trouble walking
Feeling unusually euphoric (easy laughing and feeling good)
Twitching

If you experience extreme drowsiness, dizziness, or loss of consciousness, seek medical help immediately. Caregivers should seek medical help right away if the patient is unresponsive, uncommunicative, or unable to wake up.

Important Warning: Suicidal Thoughts and Actions

Like other medications used to treat seizures, this drug may rarely increase the risk of suicidal thoughts or actions, particularly in individuals with a history of suicidal behavior. If you or your caregiver notice any new or worsening symptoms, such as:

Depression
Feeling nervous, restless, or irritable
Panic attacks
Changes in mood or behavior

contact your doctor immediately. If you experience suicidal thoughts or actions, seek medical help right away.

Low Platelet Counts and Bleeding Risk

This medication may rarely cause low platelet counts, which can increase the risk of bleeding. If you experience unexplained bruising or bleeding, contact your doctor immediately.

Other Side Effects

Most medications can cause side effects, but many people may not experience any or may only have mild side effects. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:

Feeling dizzy, sleepy, tired, or weak
Weight gain
Difficulty focusing
Headache
Dry mouth
Constipation
Increased appetite
Upset stomach
Joint pain
Nose or throat irritation

These are not all the possible side effects that may occur. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or drowsiness
  • Significant swelling of hands, feet, or ankles
  • Unexplained weight gain
  • Blurred or double vision
  • Muscle pain or weakness
  • New or worsening depression, anxiety, or suicidal thoughts
  • Agitation, restlessness, or irritability
  • Difficulty breathing or swallowing
  • Rash or hives
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
If you have kidney disease, as this may affect how your body processes the medication.
If you are breastfeeding, as you should not breastfeed while taking this medication.

Additionally, to ensure your safety, it is crucial to:

Inform your doctor and pharmacist about all medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins.
Discuss all your health problems with your doctor, as some conditions may interact with this medication.
Never start, stop, or change the dose of any medication without first consulting your doctor to confirm it is safe to do so. This medication may interact with other drugs or health conditions, and your doctor needs to be aware of all relevant information to provide the best possible care.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Before engaging in activities that require alertness or clear vision, such as driving, wait until you understand how this medication affects you.

If you experience changes in your seizures or if they worsen after starting this medication, consult your doctor promptly.

Do not abruptly stop taking this medication without first consulting your doctor, as this may increase your risk of side effects. If you need to discontinue this medication, your doctor will guide you on how to gradually stop taking it.

While taking this medication, avoid consuming alcohol. Additionally, before using marijuana, cannabis products, or prescription and over-the-counter medications that may impair your actions, discuss the potential risks with your doctor.

A severe and potentially life-threatening reaction called angioedema has been associated with this medication. Recognizable symptoms include swelling of the hands, face, lips, eyes, tongue, or throat, difficulty breathing, swallowing problems, or unusual hoarseness. If you experience any of these symptoms, seek immediate medical attention.

This medication has been linked to severe breathing problems, particularly in individuals taking certain other medications, such as opioid pain medications, or those with pre-existing lung or breathing issues. The risk may be higher in people over 65 years old, and in some cases, these breathing problems have been fatal. If you have concerns, consult your doctor.

If you are 65 years or older, exercise caution when taking this medication, as you may be more susceptible to side effects.

Men planning to father a child should discuss this medication with their doctor, as it has been shown to reduce fertility and cause sperm changes in male animals, and has also been linked to birth defects in the offspring of treated male animals. Although it is unclear if these effects occur in humans, it is crucial to weigh the potential risks and benefits.

If you are pregnant or plan to become pregnant, inform your doctor, as you will need to discuss the benefits and risks of using this medication during pregnancy.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Somnolence
  • Confusion
  • Agitation
  • Restlessness
  • Seizures
  • Coma

What to Do:

Seek immediate medical attention. There is no specific antidote. Treatment is supportive and may include gastric lavage, emesis, or hemodialysis if clinically indicated (Pregabalin is dialyzable). Call 911 or your local poison control center (e.g., 1-800-222-1222 in the US).

Drug Interactions

πŸ”΄

Major Interactions

  • CNS depressants (e.g., opioids, benzodiazepines, alcohol, barbiturates, other sedatives/hypnotics, tricyclic antidepressants, antihistamines with sedative properties): Increased risk of additive CNS depression (drowsiness, dizziness, respiratory depression, coma).
  • Angiotensin-converting enzyme (ACE) inhibitors: May increase risk of angioedema when co-administered with pregabalin.
🟑

Moderate Interactions

  • Thiazolidinediones (e.g., rosiglitazone, pioglitazone): May increase risk of weight gain and peripheral edema.
  • Gabapentin: Additive CNS effects, though not typically co-administered.

Monitoring

πŸ”¬

Baseline Monitoring

Renal function (CrCl)

Rationale: Pregabalin is primarily renally excreted; dose adjustment is necessary in renal impairment.

Timing: Prior to initiation of therapy.

Mental status/mood assessment

Rationale: To establish baseline for potential suicidal ideation or behavioral changes.

Timing: Prior to initiation of therapy.

πŸ“Š

Routine Monitoring

Efficacy (pain, seizure control, anxiety)

Frequency: Regularly during titration and maintenance.

Target: Individualized based on patient response.

Action Threshold: Lack of efficacy or worsening symptoms may require dose adjustment or alternative therapy.

Adverse effects (dizziness, somnolence, peripheral edema, weight gain, blurred vision)

Frequency: Regularly, especially during titration.

Target: Tolerable levels.

Action Threshold: Intolerable side effects may require dose reduction or discontinuation.

Renal function (CrCl)

Frequency: Periodically, especially in elderly or those with risk factors for renal decline.

Target: Maintain appropriate CrCl for dosing.

Action Threshold: Significant decline in CrCl requires dose adjustment.

Mood/behavioral changes (e.g., suicidal ideation, depression, anxiety, agitation)

Frequency: Regularly, especially during initial therapy and dose changes.

Target: Stable mood.

Action Threshold: New or worsening symptoms require immediate assessment and intervention.

πŸ‘οΈ

Symptom Monitoring

  • Dizziness
  • Somnolence
  • Peripheral edema (swelling of hands/feet)
  • Weight gain
  • Blurred vision or other visual disturbances
  • Difficulty concentrating
  • Dry mouth
  • Suicidal thoughts or behavior
  • Unusual changes in mood or behavior (e.g., agitation, depression, anxiety, panic attacks, irritability, aggression, insomnia)
  • Hypersensitivity reactions (e.g., angioedema, rash, hives, difficulty breathing)
  • Muscle pain, tenderness, or weakness (especially if accompanied by fever or malaise)
  • Signs of respiratory depression (shallow breathing, confusion, extreme drowsiness)

Special Patient Groups

🀰

Pregnancy

Pregabalin is Pregnancy Category C. Studies in animals have shown developmental toxicity (skeletal abnormalities, growth retardation, increased mortality) at doses higher than human therapeutic doses. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Patients should be enrolled in a pregnancy registry if exposed during pregnancy.

Trimester-Specific Risks:

First Trimester: Potential for increased risk of major congenital malformations, particularly neural tube defects, based on some observational data, though conflicting evidence exists. Animal studies suggest risk.
Second Trimester: Less data available, but continued exposure may contribute to growth retardation observed in animal studies.
Third Trimester: Potential for withdrawal symptoms in the neonate if discontinued abruptly before delivery. Risk of respiratory depression in neonate if used close to delivery, especially with other CNS depressants.
🀱

Lactation

Pregabalin is excreted into human milk. The amount ingested by a breastfed infant is estimated to be low (approximately 7% of the maternal weight-adjusted dose). Monitor breastfed infants for sedation, poor feeding, and weight gain. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother’s clinical need for pregabalin, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition.

Infant Risk: L3 (Moderate risk). Potential for sedation, poor feeding, and weight gain in the infant. Monitor closely.
πŸ‘Ά

Pediatric Use

Safety and efficacy have not been established in pediatric patients for most indications. For adjunctive therapy of partial onset seizures, limited data support use in children 4 years and older, with weight-based dosing and careful monitoring for adverse effects, particularly behavioral changes and weight gain.

πŸ‘΄

Geriatric Use

Elderly patients (β‰₯65 years) may experience increased incidence of adverse effects such as dizziness, somnolence, and peripheral edema. Renal function declines with age, so dose adjustments based on creatinine clearance are often necessary in this population. Start with lower doses and titrate slowly.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Pregabalin should be tapered gradually over at least 1 week when discontinuing to minimize withdrawal symptoms.
  • Patients should be advised about the potential for weight gain and peripheral edema, especially when co-administered with thiazolidinediones.
  • Monitor for signs of angioedema, particularly in patients with a history of angioedema with ACE inhibitors.
  • Due to its potential for abuse and dependence, especially in patients with a history of substance abuse, careful prescribing and monitoring are warranted.
  • Patients should be educated on the importance of reporting any suicidal thoughts or behavioral changes immediately.
πŸ”„

Alternative Therapies

  • For Neuropathic Pain: Gabapentin, Duloxetine, Venlafaxine, Amitriptyline, Nortriptyline, Carbamazepine (for trigeminal neuralgia), Topical Lidocaine.
  • For Fibromyalgia: Duloxetine, Milnacipran, Amitriptyline, Cyclobenzaprine.
  • For Partial Onset Seizures: Levetiracetam, Lamotrigine, Carbamazepine, Oxcarbazepine, Valproic acid, Phenytoin, Topiramate, Lacosamide, Brivaracetam.
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $50-$300+ per 30 capsules (generic)
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 for generic; Tier 3 or higher for brand.
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. Please read this guide carefully and review it again whenever you refill your prescription. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.